| Literature DB >> 29713464 |
Dmitriy Viderman1,2, Yekaterina Khamzina1, Zhannur Kaligozhin3, Makhira Khudaibergenova3, Agzam Zhumadilov3, Byron Crape1, Azliyati Azizan1.
Abstract
Background: Hospital Associated infections (HAI) are very common in Intensive Care Units (ICU) and are usually associated with use of invasive devices in the patients. This study was conducted to determine the prevalence and etiological agents of HAI in a Surgical ICU in Kazakhstan, and to assess the impact of these infections on ICU stay and mortality. Objective: To assess the rate of device-associated infections and causative HAI etiological agents in an ICU at the National Research Center for Oncology and Transplantation (NRCOT) in Astana, Kazakhstan.Entities:
Keywords: Blood stream infections (BSI); Hospital associated infections (HAI); Intensive care unit (ICU); Surgical site infections (SSI); Urinary tract infections (UTI); Ventilator associated pneumonia (VAP)
Mesh:
Year: 2018 PMID: 29713464 PMCID: PMC5918921 DOI: 10.1186/s13756-018-0350-0
Source DB: PubMed Journal: Antimicrob Resist Infect Control ISSN: 2047-2994 Impact factor: 4.887
Types of Hospital Associated infections in percent for each year
| Type of infection | Percent in 2014 (total number) | Percent in 2015 (total number) |
|---|---|---|
| BSI | 24.6% (28) | 18.5% (25) |
| VAP | 25.4% (29) | 29.6% (40) |
| UTI | 19.3% (22) | 18.5% (25) |
| SSI | 30.7% (35) | 33.3% (45) |
| Total | 100% (114) | 100% (135) |
BSI: Catheter-associated Blood Stream Infections, VAP: Ventilator-associated Pneumonia, UTI: Catheter-associated Urinary Tract Infections, SSI: Surgical Site Infections
Fig. 1Samples for microbiological culture and analysis were obtained from patients who presented with HAI symptoms. Blood samples, removed intravascular catheters, urine, urinary and wound catheters were also cultured for microbiological analysis if BSI, UTI or SSI were suspected. Comparison of rates of case-specific infections between 2014 and 2015 were performed. Statistically significant level was determined at a p-value < 0.05; and highly statistically significant level at a p-value of < 0.001. Statistically significant difference is noted for VAP, SSI and combined total between years 2014 and 2015 (statistical significance: *p-value< 0.05; **p-value< 0.001)
Fig. 2Samples for bacterial culture and analysis were obtained from patients who presented with HAI symptoms. Samples were cultured using standard microbiological methods; isolated bacteria were identified by standard microbiological methods according to Clinical and Laboratory Standards Institute (CLCI) specifications [12, 13]. For comparison, Chi-square test was conducted with a p-value < 0.001**. The subgroup ‘Others’ includes rare strains of bacteria (with incidence of < 5%), which were different for each year (comparing 2014 and 2015).
Fig. 3The types of HAI pathogens shown in Fig. 2 were subdivided into the types of HAI samples they were isolated from; a VAP, b BSI, c UTI, and d SSI and represented as percent (%) of total number of bacteria isolated. Samples were cultured using standard microbiological methods; isolated bacteria were identified by standard microbiological methods according to Clinical and Laboratory Standards Institute (CLCI) specifications [12, 13]